UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.647

Sortiert nach

Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape

Science (American Association for the Advancement of Science), 1996-11, Vol.274 (5291), p.1363-1366

1996

Link zum Volltext

Verfügbarkeit prüfen

Sunscreen Use and Duration of Sun Exposure: a Double-Blind, Randomized Trial

JNCI : Journal of the National Cancer Institute, 1999-08, Vol.91 (15), p.1304-1309

1999

Link zum Volltext

Verfügbarkeit prüfen

Multivariable sliding mode control for autonomous diving and steering of unmanned underwater vehicles

IEEE journal of oceanic engineering, 1993-07, Vol.18 (3), p.327-339

1993

Link zum Volltext
IEEE_Xplore

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

Journal of clinical oncology, 1992-01, Vol.10 (1), p.52-60

1992

Link zum Volltext

Verfügbarkeit prüfen

The Role of Interval Nodes in Sentinel Lymph Node Mapping and Dissection for Melanoma Patients

The Journal of nuclear medicine (1978), 2007-10, Vol.48 (10), p.1607-1613

2007

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of serial blood S100B determinations in stage IIB–III melanoma patients: A corollary study to EORTC trial 18952

European journal of cancer (1990), 2011-02, Vol.47 (3), p.361-368

2011

Link zum Volltext

Verfügbarkeit prüfen

Efficient Simultaneous Presentation of NY-ESO-1/LAGE-1 Primary and Nonprimary Open Reading Frame-Derived CTL Epitopes in Melanoma

The Journal of immunology (1950), 2000-12, Vol.165 (12), p.7253-7261

2000

Link zum Volltext

Verfügbarkeit prüfen

Advanced cutaneous squamous cell carcinoma of the head in two renal transplanted patients treated with cemiplimab

Journal of the European Academy of Dermatology and Venereology, 2022-01, Vol.36 (S1), p.53-58

2022

Link zum Volltext

Verfügbarkeit prüfen

Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNFα)

International journal of cancer, 1994-06, Vol.57 (5), p.656-663

1994

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

The Lancet (British edition), 2008-07, Vol.372 (9633), p.117-126

2008

Link zum Volltext

Verfügbarkeit prüfen

Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial

The Lancet (British edition), 2005-10, Vol.366 (9492), p.1189-1196

2005

Link zum Volltext

Verfügbarkeit prüfen

Final results of the EORTC 18871/DKG 80-1 randomised phase III trial: rIFN-α2b versus rIFN-γ versus ISCADOR M® versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasis

European journal of cancer (1990), 2004-02, Vol.40 (3), p.390-402

2004

Link zum Volltext

Verfügbarkeit prüfen

Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: A randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group

European journal of cancer (1990), 2006-11, Vol.42 (17), p.2991-2995

2006

Link zum Volltext

Verfügbarkeit prüfen

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909

The Journal of clinical investigation, 2005-03, Vol.115 (3), p.739-746

2005

Link zum Volltext

Verfügbarkeit prüfen

Expression of MAGE genes in primary and metastatic cutaneous melanoma

International journal of cancer, 1995-11, Vol.63 (3), p.375-380

1995

Link zum Volltext

Verfügbarkeit prüfen

Effector function of human tumor-specific CD8 T cells in melanoma lesions: A state of local functional tolerance

Cancer research (Chicago, Ill.), 2004-04, Vol.64 (8), p.2865-2873

2004

Link zum Volltext

Verfügbarkeit prüfen

Enhanced Generation of Specific Tumor-Reactive CTL In Vitro by Selected Melan-A/MART-1 Immunodominant Peptide Analogues

The Journal of immunology (1950), 1998-02, Vol.160 (4), p.1750-1758

1998

Link zum Volltext

Verfügbarkeit prüfen

Dacarbazine, Cisplatin, and Interferon-Alfa-2b With or Without Interleukin-2 in Metastatic Melanoma: A Randomized Phase III Trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group

Journal of clinical oncology, 2005-09, Vol.23 (27), p.6747-6755

2005

Link zum Volltext

Verfügbarkeit prüfen

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

The Journal of experimental medicine, 1999-09, Vol.190 (5), p.705-716

1999

Link zum Volltext

Verfügbarkeit prüfen

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

The Journal of experimental medicine, 1998-11, Vol.188 (9), p.1641-1650

1998

Link zum Volltext

Verfügbarkeit prüfen

Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients

Cancer research (Chicago, Ill.), 2000-08, Vol.60 (16), p.4499-4506

2000

Link zum Volltext

Verfügbarkeit prüfen

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

Journal of clinical oncology, 1996-10, Vol.14 (10), p.2653-2665

1996

Link zum Volltext

Verfügbarkeit prüfen

Clinical applications of TNF-α in cancer

Current opinion in immunology, 1998-10, Vol.10 (5), p.573-580

1998

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution

European journal of surgical oncology, 2008-06, Vol.34 (6), p.673-679

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.647

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.230)
Mit Volltextzugriff
(1.522)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Französisch
(1.209)
Englisch
(440)
Japanisch
(24)
Russisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

L'antiquité Classique
(377)
Latomus
(298)
Etudes
(47)
Productions Animales
(44)
Archéologie Médiévale
(23)
Melanoma Research
(21)
Physical Review Letters
(16)
Physical Review. C, Nuclear Physics
(16)
European Journal Of Cancer
(15)
International Journal Of Cancer
(14)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape

Sunscreen Use and Duration of Sun Exposure: a Double-Blind, Randomized Trial

Multivariable sliding mode control for autonomous diving and steering of unmanned underwater vehicles

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

The Role of Interval Nodes in Sentinel Lymph Node Mapping and Dissection for Melanoma Patients

Prognostic value of serial blood S100B determinations in stage IIB–III melanoma patients: A corollary study to EORTC trial 18952

Efficient Simultaneous Presentation of NY-ESO-1/LAGE-1 Primary and Nonprimary Open Reading Frame-Derived CTL Epitopes in Melanoma

Advanced cutaneous squamous cell carcinoma of the head in two renal transplanted patients treated with cemiplimab

Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNFα)

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial

Final results of the EORTC 18871/DKG 80-1 randomised phase III trial: rIFN-α2b versus rIFN-γ versus ISCADOR M® versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasis

Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: A randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909

Expression of MAGE genes in primary and metastatic cutaneous melanoma

Effector function of human tumor-specific CD8 T cells in melanoma lesions: A state of local functional tolerance

Enhanced Generation of Specific Tumor-Reactive CTL In Vitro by Selected Melan-A/MART-1 Immunodominant Peptide Analogues

Dacarbazine, Cisplatin, and Interferon-Alfa-2b With or Without Interleukin-2 in Metastatic Melanoma: A Randomized Phase III Trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

Clinical applications of TNF-α in cancer

Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution

Suchergebnisse filtern